Antisense modulation of glycogen synthase kinase 3 beta expression
OwnerMadeline M. Butler, Robert McKay +2inventors
InventorsMadeline M. Butler, Robert McKay, Brett P. Monia, Jacqueline Wyatt
Life of this patent
Estimating the term…
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of glycogen synthase kinase 3 beta. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding glycogen synthase kinase 3 beta. Methods of using these compounds for modulation of glycogen synthase kinase 3 beta expression and for treatment of diseases associated with expression of glycogen synthase kinase 3 beta are provided.
Claims20
An antisense compound 8 to 30 nucleobases in length targeted to a nucleic acid molecule encoding glycogen synthase kinase 3 beta, wherein said antisense compound specifically hybridizes with and inhibits the expression of glycogen synthase kinase 3 beta.
Dependencies are inferred from the claim text.